Probiotics reduce symptoms of antibiotic use in a hospital setting: A randomized dose response study

Vaccine

Volumn 32, Issue 4, 2014, Pages 458-463

  Ouwehand, Arthur C ^a   DongLian, Cai ^b   Weijian, Xu ^b   Stewart, Morgan ^c   Ni, Jiayi ^d   Stewart, Tad ^e   Miller, Larry E ^c  

^a Active Nutrition   (Finland)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SPRIM   (United States)

^d Sprim China Ltd   (China)

^e DUPONT COMPANY   (United States)

Author keywords

Antibiotic associated diarrhea; Bifidobacterium lactis; Dose response; Lactobacillus acidophilus; Lactobacillus paracasei; Probiotics

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; CLINDAMYCIN; HOWARU RESTORE; PENICILLIN DERIVATIVE; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADULT; AGED; ANTIBIOTIC ASSOCIATED DIARRHEA; ANTIBIOTIC THERAPY; ARTICLE; BIFIDOBACTERIUM ANIMALIS; BLOATING; CLOSTRIDIUM DIFFICILE INFECTION; COLONY FORMING UNIT; CONSTIPATION; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FEVER; FOOD ALLERGY; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART ARRHYTHMIA; HUMAN; HUMERUS FRACTURE; INCIDENCE; ISCHEMIC HEART DISEASE; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PARACASEI; LIQUID FECES; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTUM HEMORRHAGE; RHINORRHEA; SEA FOOD; VOMITING;

ANTIBIOTIC ASSOCIATED DIARRHEA; BIFIDOBACTERIUM LACTIS; DOSE RESPONSE; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PARACASEI; PROBIOTICS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; DIARRHEA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; PROBIOTICS;

EID: 84891625369     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.11.053     Document Type: Article

References (23)

1. Wistrom J., Norrby S., Myhre E., Erikson S., Grandström G., Lagergren L. Frequency of antibiotic-associated diarrhoea in 24462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 2001, 47:43-50.
2. McFarland L.V. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis 1998, 16:292-307.
3. McFarland L.V. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006, 101:812-822.
4. Barbut F., Petit J. Epidemiology of Clostridium difficile associated infections. Clin Microbiol Infect 2001, 7:405-410.
5. Morris A., Jobe B., Stoney M., Sheppard B.C., Deveney C.W., Deveney K.E. Clostridium difficile colitis: an increasingly aggressive iatrogenic disease?. Arch Surg 2002, 137:1096-1100.
6. Pépin J., Valiquette L., Alary M., Forget K., Pépin K., Chouinard D. Clostridium difficile associated diarrhea in a regionof Quebec from 1991 to 2003: a changing pattern of disease severity. Can Med Assoc J 2004, 171:466-472.
7. Curry J. Excerpt from Pseudomembranous Colitis 2007, http://www.emedicine.com/med/byname/Pseudomembranous-Colitis.htm.
8. FAO/WHO Guidelines for the evaluation of probiotics in food 2002, http://www.who.int/foodsafety/publications/fs_management/probiotics2/en/.
9. de Vrese M., Winkler P., Rautenberg P., Harder T., Noah C., Laue C., Ott S., Hampe J., Schreiber S., Heller K., Schrezenmeir J. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine 2006, 24:6670-6674.
10. Hempel S., Newbery S.J., Maher A.R., Wang Z., Miles J.N., Shanman R. Probiotics for the prevention and treatment of antibiotic-associated diarrhoea: a systematic review and meta-anlysis. JAMA 2012, 307:1959-1969.
11. Björksten B. Diverse microbial exposure-consequences for vaccine development. Vaccine 2012, 30:4336-4340.
12. Sazawal S., Hiremath G., Dhingra U., Malik P., Deb S., Black R.E. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 2006, 6:374-382.
13. Gao X.W., Mubasher M., Fang C.Y., Reifer C., Miller L.E. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol 2010, 105:1636-1641.
14. Engelbrektson A., Korzenik J.R., Pittler A., Sanders M.E., Klaenhammer T.R., Leyer G., Kitts C.L. Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy. J Med Microbiol 2009, 58:663-670.
15. Moher D., Schulz K.F., Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001, 285:1987-1991.
16. Massey V., Gregson D.B., Chagla A.H., Storey M., John M.A., Hussain Z. Clinical usefulness of components of the triage immunoassay, enzyme immunoassay for toxins A and B, and cytotoxin B tissue culture assay for the diagnosis of Clostridium difficile diarrhea. Am J Clin Pahol 2003, 119:45-49.
17. Mehta C.R., Patel N.R., Senchaudhuri P. Exact power and sample size computations for the Cochran-Armitage trend test. Biometrics 1998, 54:1615-1621.
18. Bartlett J. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002, 346:334-339.
19. Asha N.J., Tompkins D., Wilcox M.H. Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. J Clin Microbiol 2006, 44:2785-2791.
20. Videlock E.J., Cremonini F. Meta-analysis: probiotics in antibiotic-associated diarrhea. Aliment Pharm Ther 2012, 10.1111/j.1365-2036.2012.05104.x.
21. Rousseaux C., Thuru X., Gelot A., Barnich N., Neut C., Dubuquoy L., et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 2007, 13:35-37.
22. Ringel Y., Ringel-Kulka T., Maier D., Carroll I., Galanko J.A., Leyer G., et al. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study. J Clin Gastroenterol 2011, 45:518-525.
23. Doron S.I., Hibberd P.L., Gorbach S.L. Probiotics for prevention of antibiotic-associated diarrhea. J Clin Gastroenterol 2008, 42:S58-S63.